Reference intervals for bone turnover markers and their association with incident hip fractures in older men: The health in men study

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 1, 2015, Pages 90-99

  Paul Chubb, S A ^a,b,c   Byrnes, Elizabeth ^c   Manning, Laurens ^b   Beilby, John P ^a,c   Ebeling, Peter R ^d   Vasikaran, Samuel D ^a,c   Golledge, Jonathan ^e,f   Flicker, Leon ^b   Yeap, Bu B ^b,g  

^a ROYAL PERTH HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c PATHWEST LABORATORY MEDICINE   (Australia)

^d MONASH UNIVERSITY   (Australia)

^e JAMES COOK UNIVERSITY   (Australia)

^f TOWNSVILLE HOSPITAL   (Australia)

^g FREMANTLE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CALCIUM BINDING PROTEIN; COLLAGEN; COLLAGEN TYPE I C TERMINAL CROSS LINKED TELOPEPTIDE; HYDROXYAPATITE; N TERMINAL PROPEPTIDE OF TYPE I COLLAGEN; OSTEOCALCIN; TELOPEPTIDE; UNCLASSIFIED DRUG; UNDERCARBOXYLATED OSTEOCALCIN; COLLAGEN TYPE 1; COLLAGEN TYPE I TRIMERIC CROSS-LINKED PEPTIDE; PEPTIDE; PEPTIDE FRAGMENT; PROCOLLAGEN; PROCOLLAGEN TYPE I N-TERMINAL PEPTIDE;

AGED; ARTICLE; BLOOD SAMPLING; BONE TURNOVER; CHEMILUMINESCENCE IMMUNOASSAY; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; FOLLOW UP; GROUPS BY AGE; HIP FRACTURE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; REFERENCE VALUE; RISK ASSESSMENT; RISK FACTOR; SEASONAL VARIATION; BLOOD; BONE REMODELING; HEALTH SURVEY; HIP FRACTURES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BONE REMODELING; COLLAGEN TYPE I; HEALTH SURVEYS; HIP FRACTURES; HUMANS; INCIDENCE; MALE; OSTEOCALCIN; PEPTIDE FRAGMENTS; PEPTIDES; PROCOLLAGEN; REFERENCE VALUES; RISK FACTORS;

EID: 84920553663     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.20142646     Document Type: Article

References (40)

1. Drake MT, Khosla S. Male osteoporosis. Endocrinol Metab Clin North Am. 2012;41:629-641.
2. van Staa TP, Dennison EM, Leufkens HG, Cooper C. Epidemiology of fractures in England and Wales. Bone. 2001;29:517-522.
3. Center JR, Nguyen TV, Schneider D, Sambrook PN, Eisman JA. Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet. 1999;353:878-882.
4. Vasikaran S, Eastell R, Bruyére O, et al. Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int. 2011;22:391-420.
5. Johansson H, Odén A, Kanis JA, et al. A meta-Analysis of reference markers of bone turnover for prediction of fracture. Calcif Tissue Int. 2014;94:560-567.
6. Adami S, Bianchi G, Brandi ML, et al. Determinants of bone turnover markers in healthy premenopausal women. Calcif Tissue Int. 2008;82:341-347.
7. Eastell R, Garnero P, Audebert C, Cahall DL. Reference intervals of bone turnover mark ers in healthy premenopausal women: results from a cross-sectional European study. Bone. 2012;50:1141-1147.
8. Glover SJ, Gall M, Schoenborn-Kellenberger O, et al. Establishing a reference inter val for bone turnover markers in 637 healthy, young, premenopausal women from the United Kingdom, France, Belgium, and the United States. J Bone Miner Res. 2009;24:389-397.
9. Glover SJ, Garnero P, Naylor K, Rogers A, Eastell R. Establishing a reference range for bone turnover markers in young, healthywomen. Bone. 2008;42:623-630.
10. Jenkins N, BlackM,Paul E, Pasco JA, KotowiczMA,Schneid erHG. Age-related reference intervals for bone turnover markers from an Australian reference population. Bone. 2013;55:271-276.
11. Olmos JM, Hernández JL, Martínez J, Pariente E, Llorca J, González-Macías J. Bone turnover markers in Spanish adult men. The Camargo Cohort Study. Clin Chim Acta. 2010;411:1511-1515.
12. Szulc P, Chapuy MC, Meunier PJ, Delmas PD. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest. 1993;91:1769-1774.
13. Vergnaud P, Garnero P, Meunier PJ, Bréart G, Kamihagi K, Delmas PD. Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: The EPIDOS Study. J Clin Endocrinol Metab. 1997;82:719-724.
14. Luukinen H, Käkö nen SM, Pettersson K, et al. Strong prediction of fractures among older adults by the ratio of carboxylated to total serum osteocalcin. J Bone Miner Res. 2000;15:2473-2478.
15. Norman PE,Flicker L,Almeida OP,Hankey GJ,Hyde Z,Jamrozik K. Cohort profile: The Health InMenStudy (HIMS Int J Epidemiol. 2009 38 48-52.
16. Holman CD, Bass AJ, Rosman DL, et al. A decade of data linkage in Western Australia: strategic design, applications and benefits of the WA data linkage system. Aust Health Rev. 2008;32:766-777.
17. Almeida OP, Flicker L, Norman P, et al. Association of cardiovascular risk factors and disease with depression in later life. Am J Geriatr Psychiatry. 2007;15:506-513.
18. Alfonso H, Beer C, Yeap BB, Hankey GJ, Flick er L, Almeida OP. Perception of worsening health predicts mortality in older men: The Health In Men Study (HIMS). Arch Gerontol Geriatr. 2012;55: 363-368.
19. Levey AS, Stevens LA, Schmid CH, et al.Anew equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604-612.
20. Gundberg CM, Nieman SD, Abrams S, Rosen H. Vitamin K status and bone health: an analysis of metho ds for determination of undercarboxylated osteocalcin. J Clin Endocrinol Metab. 1998;83: 3258-3266.
21. R Core Development Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2011.
22. Solberg HE. The theory of reference values. Part 5. Statistical treatment of collected reference values. Determination of reference limits. J Clin Chem Clin Biochem. 1983;21:749-760.
23. Vasikaran SD, Chubb SA, SchneiderHG.Towards optimising the provision of laboratory services for bone turnover markers. Pathology. 2014;46:267-273.
24. Hu WW, Zhang Z, He JW, et al. Establishing reference intervals for bone turnover markers in the healthy Shanghai population and the relationship with bone mineral density in postmenopausal women. Int J Endocrinol. 2013;2013:513925.
25. Bauer DC, Garnero P, Harrison SL, et al. Biochemical markers of bone turnover, hip bone loss, and fracture in older men: The MrOS study. J Bone Miner Res. 2009;24:2032-2038.
26. Meier C, Nguyen TV, Center JR, Seibel MJ, Eisman JA. Bone resorption and osteoporotic fractures in elderly men: The Dubbo Osteoporosis Epidemiology Study. J Bone Miner Res. 2005;20:579-587.
27. Szulc P, Montella A, Delmas PD. High bone turnover is associated with accelerated bone loss but not with increased fracture risk inmen aged 50 and over: The prospective MINOS study. Ann Rheum Dis. 2008;67:1249-1255.
28. Yoshimura N, Muraki S, Oka H, Kawaguchi H, Nakamura K, Akune T. Biochemical markers of bone turnover as predictors of osteoporosis and osteoporotic fractures in men and women: 10-year follow-up of the Taiji cohort. Mod Rheumatol. 2011;21:608-620.
29. Daly RM, Gagnon C, Lu ZX, et al. Prevalence of vitamin D deficiency and its determinants in Australian adults aged 25 years and older : a national, population-based study. Clin Endocrinol (Oxf). 2012;77:26-35.
30. Hirani V, Cumming RG, Blyth FM, et al. Vitamin D status among older community dwelling men living in a sunny count ry and associations with lifestyle factors: The Concord Health and Ageing in MenProject, Sydney, Australia. J Nutr Health Aging. 2013;17:587-593.
31. Midtby M, Magnus JH, Joakimsen RM. The TromsøSt udy: a population-based study on the variation in bone formation markers with age, gender, anthropometry and season in both men and women. Osteoporos Int. 2001;12:835-843.
32. Pasco JA, Henry MJ, Kotowicz MA, et al. Seasonal periodicity of serum vitamin D and parathyroid hormone, bone resorption, and fractures: The Geelong Osteoporosis Study. J Bone Miner Res. 2004; 19:752-758.
33. Woitge HW, Scheidt-Nave C, Kissling C, et al. Seasonal variation of biochemical indexes of bone turnover: results of a population-based study. J Clin Endocrinol Metab. 1998;83:68-75.
34. Menon RK, Gill DS, Tho mas M, Kernoff PB, Dandona P. Impaired carboxylation of osteocalcin in warfarin-treated patients. J Clin Endocrinol Metab. 1987;64:59-61.
35. Blumsohn A, Hannon RA, Eastell R. Apparent instability of osteocalcin in serum as measured with different commercially available immunoassays. Clin Chem. 1995;41:318-319.
36. Brandt J,KroghTNJensenCHFrederiksen JK, Teisner B. Thermal instab ility of the trimeric structure of the N-terminal propeptide of human procollagen type I in relation to assay technology Clin Chem. 1999 45 47-53.
37. Garnero P, Vergnaud P, Hoyle N. Evaluation of a fully automated serum assay for total N-terminal propeptide of type I collagen in postmenopausal osteoporosis. Clin Chem. 2008;54:188-196.
38. Okabe R, Nakatsuka K, Inaba M, et al. Clinical eval uation of the Elecsys-CrossLaps serum assay, a new assay for degradation products of type I collagen C-telopeptides. Clin Chem. 2001;47:1410-1414.
39. Booth SL, Dallal G, Shea MK, Gundberg C, Pet erson JW, Dawson-Hughes B. Effect of vitamin K supplementation on bone loss in elderly men and women. J Clin Endocrinol Metab. 2008;93:1217-1223.
40. Barr EL, Tonkin AM, Welborn TA, Shaw JE. Validity of self-reported cardiovascular disease events in comparison to medical record adjudication and a statewide hospital morbidity database: The AusDiab study. Intern Med J. 2009;39:49-53.